Tech Company Financing Transactions
Harmonic Discovery Funding Round
Innovation Endeavors, Boom Capital and Caffeinated Capital participated in a $8 million Seed funding round for Harmonic Discovery. The round was announced on 9/8/2022.
Transaction Overview
Company Name
Announced On
9/8/2022
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Innovation Endeavors (Lead Investor) (Joel Dudley)
Proceeds Purpose
The company intends to use the funds to advance its drug discovery platform and pipeline by expanding its leadership team, building proprietary chemical libraries, and scaling its laboratory operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101, 6th Ave 3rd Fl
New York, NY 10013
USA
New York, NY 10013
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded in 2021 and headquartered in New York City. We are a drug discovery company developing a new generation of therapeutics that embrace the complexity of disease. Currently available approaches for creating drugs work on the principal of finding one drug-one protein 'magic bullets'. However, diseases such as cancer and autoimmunity are often the result of several dysregulated proteins across many distinct biological pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rayees Rahman
Chief Operating Officer
Jason Lee
Chief Scientific Officer
Marcel Patek
Browse more venture capital transactions:
Prev: 9/8/2022: Hebbia venture capital transaction
Next: 9/8/2022: Live Earth venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs